Slideshow

Medical Nutrition Therapy for Dyslipidemia: Costs and Benefits

Author(s):

Veronica Hackethal MD

Medical nutrition therapy for hyperlipidemia management is widely recommended by clinical guidelines. Is it cost-effective?

Related Videos
Transformations in Aortic Disease Management with Mehrdad Ghoreishi, MD | Image Credit: Baptist Health South Florida
Experts' Perspectives: Top Stories in Cardiology for 2024
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
The APAC Recap: Dyslipidemia at CAPP Live 2024 with Viet Le, DMSc, PA-C | Image Credit: APAC
HCPLive Lipoprotein Apheresis Special Report thumbnail
HCPLive Lipoprotein Apheresis Special Report thumbnail
HCPLive Lipoprotein Apheresis Special Report thumbnail
Related Content
FDA Approves Chenodiol Tablets for Cerebrotendinous Xanthomatosis | Image Credit: US Food and Drug Administration
February 21st 2025

FDA Approves Chenodiol Tablets for Cerebrotendinous Xanthomatosis

Connor Iapoce
Prof. Kausik Ray: Inclisiran Data at ESC Congress 2020
September 3rd 2020

Prof. Kausik Ray: Inclisiran Data at ESC Congress 2020

Patrick Campbell
Sotagliflozin Cuts MACE Risk By 23% in Patients with Type 2 Diabetes, CKD | Image Credit: Mount Sinai
February 18th 2025

Sotagliflozin Cuts MACE Risk By 23% in Patients with Type 2 Diabetes, CKD

Connor Iapoce
The State of Preventive Cardiology
August 28th 2020

The State of Preventive Cardiology

Kevin Kunzmann
The HCPFive: Top News for Healthcare Providers from the Week of 02/09 | Image Credit: HCPLive
February 16th 2025

The HCPFive: Top News for Healthcare Providers from the Week of 02/09

Connor Iapoce
Patient Enrollment Low in Cardiovascular Clinical Trials in the US | Image Credit: Baylor Scott and White Health
February 14th 2025

Patient Enrollment Low in Cardiovascular Clinical Trials in the US

Connor Iapoce
© 2025 MJH Life Sciences

All rights reserved.